Pesquisar
LivaNova PLC
LIVNAdicionar à lista de desejos
80.140USD
-0.910-1.12%
Fechamento 07-31 16:00（ET）Cotações atrasadas em 15 min
4.40BValor de mercado
40.53P/L TTM
Mais detalhes de LivaNova PLC Empresa
LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, and Neuromodulation. Its Cardiopulmonary segment is engaged in the design, development, manufacture, marketing, and sale of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories. Its Neuromodulation segment is engaged in the design, development, manufacture, marketing, and sale of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). Its principal Neuromodulation product, the VNS Therapy System, consists of an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals.
Informações de LivaNova PLC
Código da empresaLIVN
Nome da EmpresaLivaNova PLC
Data de listagemOct 19, 2015
CEOMakatsaria (Vladimir A)
Número de funcionários2900
Tipo de títulosOrdinary Share
Fim do ano fiscalOct 19
Endereço20 Eastbourne Terrace
CidadeLONDON
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited Kingdom
Código postalW2 6LG
Telefone442033250662
Sitehttps://www.livanova.com/
Código da empresaLIVN
Data de listagemOct 19, 2015
CEOMakatsaria (Vladimir A)
Executivos da empresa LivaNova PLC
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Alex Shvartsburg
Mr. Alex Shvartsburg
Chief Financial Officer
Chief Financial Officer
44.65K
--
Mr. William A. Kozy
Mr. William A. Kozy
Independent Chairman of the Board
Independent Chairman of the Board
37.57K
+13.31%
Ms. Stephanie Bolton
Ms. Stephanie Bolton
President, Global Epilepsy
President, Global Epilepsy
22.19K
+42.53%
Mr. Todd C. Schermerhorn
Mr. Todd C. Schermerhorn
Independent Director
Independent Director
12.62K
+28.18%
Dr. Sharon O'Kane, Ph.D.
Dr. Sharon O'Kane, Ph.D.
Independent Director
Independent Director
11.30K
--
Franco Poletti ,
Franco Poletti ,
President, Cardiopulmonary Business Unit
President, Cardiopulmonary Business Unit
10.97K
+17.36%
Ms. Brooke Story
Ms. Brooke Story
Independent Director
Independent Director
9.79K
+36.33%
Mr. Francesco Bianchi
Mr. Francesco Bianchi
Independent Director
Independent Director
9.58K
+24.58%
Mr. Michael Damon Hutchinson
Mr. Michael Damon Hutchinson
Senior Vice President, Chief Legal Officer, Company Secretary
Senior Vice President, Chief Legal Officer, Company Secretary
6.80K
--
Ahmet Tezel
Ahmet Tezel
Senior Vice President, Chief Innovation Officer
Senior Vice President, Chief Innovation Officer
6.09K
+31.74%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Alex Shvartsburg
Mr. Alex Shvartsburg
Chief Financial Officer
Chief Financial Officer
44.65K
--
Mr. William A. Kozy
Mr. William A. Kozy
Independent Chairman of the Board
Independent Chairman of the Board
37.57K
+13.31%
Ms. Stephanie Bolton
Ms. Stephanie Bolton
President, Global Epilepsy
President, Global Epilepsy
22.19K
+42.53%
Mr. Todd C. Schermerhorn
Mr. Todd C. Schermerhorn
Independent Director
Independent Director
12.62K
+28.18%
Dr. Sharon O'Kane, Ph.D.
Dr. Sharon O'Kane, Ph.D.
Independent Director
Independent Director
11.30K
--
Franco Poletti ,
Franco Poletti ,
President, Cardiopulmonary Business Unit
President, Cardiopulmonary Business Unit
10.97K
+17.36%
Perguntas frequentes
Quem são os cinco principais acionistas de LivaNova PLC?
Os cinco principais acionistas de LivaNova PLC são: Mr. Alex Shvartsburg
Quantas instituições possuem ações da LivaNova PLC (LIVN)?
Em 2026Q1, 609 instituições possuíam ações da LivaNova PLC, com valor de mercado aproximado de 60.49M, representando 110.12% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -11258417.00.